{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-078941","form_type":"8-K","ticker":"RYTM","cik":"0001649904","company_name":"RHYTHM PHARMACEUTICALS, INC.","filed_at":"2024-07-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.958172+00:00","generated_at":"2026-05-31T22:09:13.409223+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Rhythm Pharmaceuticals files prospectus for resale of 3.1M shares by selling stockholders","bullets":["Registration covers up to 3,124,995 common shares held by certain stockholders to satisfy registration rights.","Shares issuable upon conversion of Series A Convertible Preferred Stock sold on April 15, 2024 for $150M.","Legal opinion of Latham & Watkins filed as Exhibit 5.1 and incorporated into S-3ASR registration statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-078941","json":"https://secwatch.observer/filing/0001104659-24-078941.json","markdown":"https://secwatch.observer/filing/0001104659-24-078941.md","text":"https://secwatch.observer/filing/0001104659-24-078941.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649904/000110465924078941/0001104659-24-078941-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649904/000110465924078941/tm2418975d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T22:09:13.409223+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}